Swiss Nordic Bio in Zurich is a high-level partnering and investor event where Swiss and Nordic biotech startups, pharmaceutical companies and investors meet. Swiss Nordic Bio carries 15 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organized by the Nordic countries in cooperation with Swiss partners.

The conference has a broad focus within biotech and pharma (drug development, drug delivery, biomaterials, medical device, diagnostics, contract manufacturing, CRO, etc.) and gathers small, early-stage companies as well as global, commercial corporations.

CEO Thomas Lenz met many interesting contacts at this well-organized event and it’s very obvious that Milmed is an interesting unique product among the life science people.